費用対効果評価の政策的導入の必要性
Findings on Internal Medicine Reported byInvestigators at Univer... 1/2 ページ

NEWSWIRES

 May 25, 2018

 newswires



Findings on Internal Medicine Reported by
Investigators at University of Tokyo (AnEvaluation of Clinical Economics and Casesof Cost-effectiveness)
Obesity, Fitness &Wellness Week

By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Healthand Medicine - Internal Medicine is the subject of a report. According to news reporting originatingfrom Tokyo, Japan, by NewsRx editors, the research stated, "In order to maintain and develop auniversal health insurance system, it is crucial to utilize limited medical resources effectively. In thiscontext, considerations are underway to introduce health technology assessments (HTAs), such as
cost-effectiveness analyses (CEAs), into the medical treatment fee system."
Our news editors obtained a quote from the research from the University of Tokyo, "CEAs, which is thegeneral term for these methods, are classified into four categories, such as cost-effectiveness analyses
based on performance indicators, and in the comparison of health technologies, the incremental costeffectiveness ratio (ICER) is also applied. When I comprehensively consider several Japanese studies
based on these concepts, I find that, in the results of the analysis of the economic performance of
healthcare systems, Japan shows the most promising trend in the world."
According to the news editors, the research concluded: "In addition, there is research indicating thesuperior cost-effectiveness of Rituximab against refractory nephrotic syndrome, and it is expected that
health economics will be actively applied to the valuation of technical innovations such as drug
discovery."

医療価値評価の理論・手法の解説
https://insurancenewsnet.com/oarticle/findings-on-internal-medici...
2018/07/08

Findings on Internal Medicine Reported 費用対効果評価の政策的導入の必要性
by Investigators at Univer... 2/2 ページ

For more information on this research see: An Evaluation of Clinical Economics and Cases of Costeffectiveness. Internal Medicine, 2018;57(9):1191-1200. Internal Medicine can be contacted at: Japan
Soc Internal Medicine, 34-3 3-Chome Hongo Bunkyo-Ku, Tokyo, 113, Japan. (Wiley-Blackwell www.wiley.com/ (http://www.wiley.com/); Internal Medicine - onlinelibrary.wiley.com/journal/10.1111/(http://onlinelibrary.wiley.com/journal/10.1111/)(ISSN)1445-5994)
The news editors report that additional information may be obtained by contacting T. Takura,
University of Tokyo, Grad Sch Med, Dept. of Healthcare Econ & Hlth Policy, Tokyo, Japan (see also
Health and Medicine - Internal Medicine(http://www.newsrx.com/search/topics/Health+and+Medicine+-+Internal+Medicine)).
The direct object identifier (DOI) for that additional information is:https://doi.org/10.2169/internalmedicine.9835-17 (https://doi.org/10.2169/internalmedicine.9835-17). This
DOI is a link to an online electronic document that is either free or for purchase, and can be yourdirect source for a journal article and its citation.
Keywords for this news article include: Tokyo, Japan, Asia, Internal Medicine, Health and Medicine,
University of Tokyo.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright2018, NewsRx LLC© 2018 InsuranceNewsNet.com, Inc. All rights reserved.

医療価値評価の理論・手法の解説
https://insurancenewsnet.com/oarticle/findings-on-internal-medici...
2018/07/08